Batavia eyes Horizon CHO cell tech to develop anti-Zika antibody
Batavia Biosciences signs a license agreement to use Horizon Discovery’s cell line expression system to produce a Zika virus-neutralizing antibody.
Archives for September 3, 2019
Freenome inks biomarker development deal with ADC Therapeutics
Freenome’s multiomics platform is being used in a Phase II clinical trial to help identify patients most likely to respond to ADC Therapeutics’ antibody drug conjugate.
Orgenesis reports record revenue as it looks to develop scalable processing solutions for cell therapies
Orgenesis is developing a ‘distributed’ processing solution – backed by its point-of-care cell therapy platform and CDMO business – to provide approved cell therapies to patients at a fraction of today’s costs, says company executive.
Idorsia adopts Arkivum service for data returning from CROs
Arkivum to create an e-archive for Idorsia to store and manage its large amount of data regarding products returned from CROs, after the latter’s separation from Actelion.
Kiel University and Hovione to develop high-dose inhalation formulations
Hovione to work with Kiel University on a dry-powder inhaler, enabling large-dose drug administration under a collaboration agreement.
908 Devices launches a Rebel-lion in media analyzing
908 Devices launches Rebel, a bioprocess analyzer, enabling researchers to conduct their own cell culture media analysis to accelerate process development ‘by weeks’.
Strides acquires US capsule facility, set to invest further $10m
Strides acquires the only FDA-approved integrated soft gel capsule manufacturing facility in the US, owned by Micelle, to support its operations in India.
Innovate UK provides grant for cell therapy preservation hydrogel
Atelerix to work on the development of gel stabilisation technologies enabling room temperature storage of Rexgenero’s cell therapy candidate, under an Innovate UK grant.